Ushering in 2025—What’s New in Pigmentary Disorders—New Treatments, Toughest Challenges, and What’s on the Horizon!
Welcome back, MedscapeLIVE! Dermatology readers! We hope you’re having a stellar 2025 personally and professionally. A lot is happening in dermatology, and this can especially be seen in treatment approaches for pigmentary disorders. For this issue, we decided to talk to some faculty of the upcoming 3rd Annual Pigmentary Disorders Exchange Symposium.
Scroll down for some pearls that faculty will share at the Pigmentary Disorders Exchange (PDE) Symposium in June. We also candidly discuss the more difficult types of pigmentary disorder cases—and the best tools in their clinical arsenal to tackle them, the evolution of the dermatologic specialization of pigmentary disorders—and where it’s going, and what the Pigmentary Disorders Exchange Symposium offers and why it is unique.
Need to learn what’s new in vitiligo, chemical peels, photodamage treatment options, melasma therapies, and more? Read on to see what the experts share prior to their presentations this June.
Need CME? We’ve got you covered! Check out these critical CME conference opportunities to plan ahead and get your CME requirements for 2025 lined up:
Pigmentary Disorders Exchange Symposium
June 7 - 8, 2025 | Chicago, IL
Register here!
26th Annual Las Vegas Dermatology Seminar
September 11-13, 2025 | Las Vegas, NV
For more info, click here!
October 3-5, 2025 | New York, NY
For more info, click here!
Don’t miss this month’s Derm Resource section—which includes articles from JAMA Dermatology, Dermatology News, Cutis, NEJM and more. Thank you to these thought leaders for sharing their perspectives. Please contact me at colleen@cmhadvisors.com with comments or suggestions. Thanks for reading!—Colleen Hutchinson
Pearls that faculty will share in these upcoming PDE presentations:
Dr. IItefat Hamzavi/ Surgical Therapies for Vitiligo: How to make vitiligo surgery accessible to more patients by training dermatologists on how to do this technique. We will provide basic tools and discuss a new kit which makes the process much easier.
Dr. Kachiu Lee/ Procedural Modalities for the Management of Photodamage: Chemical Peels & Beyond: Peels are multimodality tools that can be used to treat a variety of conditions - acne, photodamage, melasma, wrinkles, and much more!
Dr. John Harris/ New Discoveries in Pathogenesis of Vitiligo: The impact of having vitiligo is important to our patients. It is treatable using conventional approaches that include phototherapy and topical immunosuppression. Emerging therapies are even more effective, providing an exciting opportunity for our patients. Come and learn how to better care for your patients using cutting-edge clinical approaches and novel therapeutics.
Dr. Seaver Soon/ Procedural Treatments: Chemical Peels: I will be discussing the role of chemical peels in the treatment of melasma, as well as moderating a live, on-stage demonstration of superficial, medium and deep chemical peeling. This live, on-stage procedure format will be highly educational and practical!
Dr. Kachiu Lee/ Medium Depth Chemical Peeling: We'll go through the histology and evidence supporting medium depth peeling and also review the ideal patient and different types of medium depth peel.
Dr. Heather Woolery-Lloyd/ Melasma—Topical and Oral Therapies: I will be talking about some of the newest topical alternatives to hydroquinone for melasma. I will also discuss treatment algorithms to manage melasma with topical and oral therapies.
Dr. Passeron/ Unveiling the Biology of Pigmentation: Molecular Pathways and Clinical Implications: The skin pigmentation process is a very complex and tightly regulated process. I will discuss the main pathways and actors involved, and I will focus my talk on how this can help physicians to better understand and to treat pigmentary disorders.
What are some best practice pointers that attendees will leave with regarding use of chemical peels?
Dr. Woolery-Lloyd: Attendees will learn how to incorporate peels into a clinical practice with an emphasis on safety.
Dr. Soon: For patients at risk for post-inflammatory hyperpigmentation, priming with adapalene and hydroquinone, and post-procedure treatment with a short course of topical mid-potency steroid and a tinted mineral sunscreen are a must!
What does the Pigmentary Disorders Exchange Symposium offer that other meetings don’t?
Dr. Hamzavi: We don't have to explain why pigmentary disorders are important. We focus on how to improve the conditions with experts who have decades of experience.
Dr. Harris: The PDE Symposium assembles experts in pigmentary diseases from across the country and all over the world who provide a breadth of coverage for attendees that is not available elsewhere. It also provides an opportunity for attendees to engage with speakers formally and informally during the conference, building relationships to enhance learning beyond didactics and promote lifelong learning.
Dr. Passeron: Great lectures by international experts, and sharing experiences with the attendees to help us all better take care of our patients suffering from pigmentary disorders.
Dr. Soon: The rich exchange of knowledge between experts in pigmentary disorders, as well as learning what is on the horizon.
How would you describe the evolution of the dermatologic specialization of pigmentary disorders and where do you see it going?
Dr. Harris: Pigmentary disorders have been recognized for thousands of years, but significant progress on understanding their causes and developing new treatments has only recently emerged with exciting options for our patients like never before. Come and learn about the tremendous trajectory of learning and treatment for these impactful disorders.
Dr. Hamzavi: The impact of these conditions on the mental health and social health of patients is prompting more interest in the field.
Dermatology Resource Section:
JAMA Dermatology—Viewpoint: Measuring the Carbon Footprint of Dermatology
NEJM Original Research: Remibrutinib in Chronic Spontaneous Urticaria
Dermatology News New Bifunctional Drug Shows Sustained Effect in Alopecia Areata
Dermatology News MedBrief: Chronic Skin Effects Persist After Cancer Immunotherapy
Loading ...